Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Gan Shuangbi for Intestinal Function Recovery After Cesarean Section
NCT06347770Phase 1Recruiting
- Sponsor
- Zheli (Shanghai) Biotechnology
- Start
- Jan 2024
- Primary completion
- Mar 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bifidobacterium longum in postoperative recovery (2 arms), sponsored by Zheli (Shanghai) Biotechnology. Primary endpoints: Anal exhaust time at Day 4 and First defecating time at Day 4. Started Jan 2024; status: recruiting.
02
Drugs
bifidobacterium longum
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on NCT06347770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347770.